CoviTREM-1 consortium, composed of Inotrem, Nancy and Limoges teaching hospitals, announces it has completed patients’ inclusion for its COVID-19 Phase IIa clinical study
February 3, 2021
Paris, Limoges, Nancy (France). February 3rd, 2021 – Today, the CoviTREM-1 consortium, regrouping Nancy and Limoges teaching hospitals with Inotrem, a biotechnology company specializing in